从基因型到表型:增强剂如何控制血液形成中的基因表达和细胞身份
Roger Mulet-Lazaro1,2, Ruud Delwel1,2
1Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
HemaSphere
|November 13, 2023
概括
增强剂在血液细胞发育过程中控制基因表达 (血液形成). 这些DNA序列的失调与白血病和淋巴瘤等血液癌症有关.
科学领域:
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
背景情况:
- 血细胞起源于造血干细胞 (HSC),并通过造血过程发展.
- 转录程序决定了细胞多样性,增强剂在调节基因表达方面发挥着关键作用.
- 调节失调的增强剂可能导致瘤基因表达失误和造血性恶性瘤.
研究的目的:
- 解释增强剂在基因调节中的功能.
- 专注于增强剂在正常和恶性血液形成中的作用.
- 讨论白血病和淋巴瘤中增强器失调的机制.
主要方法:
- 审查关于增强剂和血液形成的现有文献.
- 增强剂功能的分析,以控制血液发育的主调节器.
- 讨论推动增强剂失调在血液形成癌症的机制.
主要成果:
- 增强剂是关键的DNA元素,它们与转录因子结合,以调节基因转录.
- 在血液形成过程中,特定的增强剂列表被激活,以驱动细胞分化.
- 异常增强剂活性是白血病和淋巴瘤发展的重要因素.
结论:
- 增强剂对于正常血液形成所需的精确转录控制至关重要.
- 了解增强器失调提供了对血液形成性恶性瘤的发病过程的见解.
- 向增强器功能障碍可能为血液癌症提供新的治疗策略.
相关概念视频
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Overview of Hematopoiesis
4.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.1K
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K


